Show Cart
PipelineReview.com
Home
My cart / Checkout
Log in
Contact Us
Home
News Channels
Antibodies
DNA, RNA & Cells
Protein & Peptides
Small Molecules
Vaccines
More News
Free Newsletters
La Merie Biologics
New Product Release Alert
Reports
Reports
Competitor Analysis
LMP Full Report
Brief Report
Monthly Tracking Reports
FREE Reports
FREE Reports
FREE Downloads
Offers
Press Room
About Us
Home
News Channels
Antibodies
DNA, RNA & Cells
Protein & Peptides
Small Molecules
Vaccines
More News
Free Newsletters
La Merie Biologics
New Product Release Alert
Reports
Reports
Competitor Analysis
LMP Full Report
Brief Report
Monthly Tracking Reports
FREE Reports
FREE Reports
FREE Downloads
Offers
Press Room
About Us
Home
News Channels
News Channels
20 Apr 2018
Argos Therapeutics Reports Results of Interim Analysis of the ADAPT Trial and Announces Review of Strategic Alternatives
20 Apr 2018
GW Pharmaceuticals and U.S. Subsidiary Greenwich Biosciences Announces the Unanimous Positive Result of FDA Advisory Committee Meeting for First Plant-Based Pharmaceutical Cannabidiol Treatment for Seizures in Patients with Two Rare, Severe Forms of Epile
20 Apr 2018
AB Science announces that the CHMP has adopted a negative opinion for the marketing authorization of masitinib in Amyotrophic Lateral Sclerosis
20 Apr 2018
New Novartis analyses at AAN show siponimod's efficacy on disability and cognition in secondary progressive MS patients
20 Apr 2018
UCB to expand epilepsy portfolio with strategic acquisition of Midazolam Nasal Spray from Proximagen
19 Apr 2018
U.S. Food and Drug Administration Accepts Supplemental Biologics License Application for Opdivo (nivolumab) in Previously Treated Patients with Small Cell Lung Cancer and Grants Priority Review
19 Apr 2018
Synlogic Doses First Subject in Phase 1/2a Trial of SYNB1618 for Treatment of Phenylketonuria
19 Apr 2018
InteRNA Demonstrates Preclinical Proof-of-Concept for Lead microRNA Candidate INT-1B3 in a Range of Cancer Models at 2018 AACR Annual Meeting
19 Apr 2018
NovaDigm Therapeutics Announces Initiation of Phase 2a Clinical Trial of NDV-3A in Staphylococcus aureus
19 Apr 2018
Pfenex and NT Pharma Enter into a Development and License Agreement for Pfenex's PF708 Therapeutic Equivalent Candidate to Forteo
19 Apr 2018
US FDA Approves TAGRISSO® (osimertinib) As 1st-Line Treatment For EGFR-Mutated Non-Small Cell Lung Cancer
19 Apr 2018
Xencor Presents Preclinical Data on XmAb®24306, Introduces XmAb® IL15 Bispecific Platform at American Association for Cancer Research (AACR) 2018 Annual Meeting
19 Apr 2018
OBI Pharma Announces FDA Clearance of OBI-3424 IND Application for A Phase I/II Study Targeting AKR1C3 Solid Tumors
19 Apr 2018
Mesoblast Clinical Program Update for MPC-150-IM in Patients With Chronic Heart Failure
19 Apr 2018
AzurRx BioPharma Announces Positive Preclinical Data with AZX1103
19 Apr 2018
Checkpoint Therapeutics Reports Preclinical Data on BET Inhibitor CK-103 at the American Association for Cancer Research Annual Meeting
19 Apr 2018
OncoMed Presents Multiple Preclinical Abstracts Related to Immuno-Oncology Programs at the 2018 American Association for Cancer Research Annual Meeting
19 Apr 2018
Adamas Announces Final Results from the Two-Year Phase 3 Open-Label Study of GOCOVRI™ in Parkinson’s Disease Patients with Dyskinesia
19 Apr 2018
Qu Biologics Begins Phase 2 Clinical Trial in Crohn’s Disease
18 Apr 2018
Obsidian Therapeutics Presents Preclinical Data from Regulated Cytokine Programs that Enable CAR-T Therapies with Controllable Functions
Page 1 of 2097
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
Currencies
Australian dollar $
British pound £
Canadian dollar $
Danish krone kr
Euro €
Japanese yen ¥
Swedish krona kr
Swiss franc CHF
United States dollar $
Shopping cart
Cart empty
Please wait
Latest report
Competitor Analysis: CDK9 and Mcl-1 Inhibitors
Featured Products
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends
mRNA Vaccines & Therapeutics 2017: an industry analysis of technologies, pipelines, stakeholders and deals
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities
Recommended Report
Blockbuster Biologics 2017: Sales of Recombinant Therapeutic Antibodies & Proteins
Currencies
Australian dollar $
British pound £
Canadian dollar $
Danish krone kr
Euro €
Japanese yen ¥
Swedish krona kr
Swiss franc CHF
United States dollar $
Shopping cart
Cart empty
Please wait
Latest report
Competitor Analysis: CDK9 and Mcl-1 Inhibitors
Featured Products
Intracellular Targets made druggable by TCR-like Antibodies, TCR Fusion Proteins & Cell-Penetrating Biologics 2018: an industry analysis of technologies, stakeholders, deals & trends
mRNA Vaccines & Therapeutics 2017: an industry analysis of technologies, pipelines, stakeholders and deals
The Oncolytic Virus Landscape 2017: an analysis of pipeline, stakeholders, deals, industry trends & opportunities
Recommended Report
Blockbuster Biologics 2017: Sales of Recombinant Therapeutic Antibodies & Proteins
La Merie Biologics
FREE Weekly News Bulletin
2017 Sales of
Antibodies & Proteins
Get it now
New Product Alert
For La Merie Publishing
Top